---
title: "Selank"
slug: "selank"
type: "compound"
category: "Cognitive"
url: "https://peptidesciencethailand.com/compounds/selank"
description: "A tuftsin-based anxiolytic peptide that modulates GABA receptor gene expression without sedation. Research overview, dosing, and intranasal delivery notes."
---
# Selank

*Anxiolytic Nootropic, GABAergic Modulation for Calm Focus*

**Category:** Cognitive  
**Format:** Nasal Spray Prep  
**Amount:** 15mg  
**Purity:** >99.6% (HPLC)

## Overview

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences as an analogue of the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg). By extending tuftsin's tetrapeptide sequence with a Pro-Gly-Pro tripeptide tail, a structural motif that enhances metabolic stability, researchers created a compound with significantly improved bioavailability and an expanded pharmacological profile that encompasses both anxiolytic and nootropic properties.

Selank's primary mechanism of action involves modulation of the GABAergic system, the brain's principal inhibitory neurotransmitter network. Research has demonstrated that Selank influences the expression of GABA-A receptor subunit genes, particularly the alpha-2 and alpha-6 subunits, which are associated with anxiolytic effects without sedation. Unlike benzodiazepines, which enhance GABA-A receptor function through allosteric modulation and carry significant dependence risk, Selank modulates GABA signaling through gene expression changes, a fundamentally different and more physiological mechanism that does not produce tolerance, dependence, or withdrawal.

Beyond GABAergic modulation, Selank influences serotonergic neurotransmission. Research published in the Bulletin of Experimental Biology and Medicine demonstrated that Selank modulates the metabolism of serotonin and its metabolites in the brain, particularly in the hypothalamus and frontal cortex. This serotonergic modulation contributes to its mood-stabilizing and anxiolytic properties, operating through a different pathway than SSRI medications but with complementary effects on emotional regulation.

Selank also affects the dopaminergic system, though its dopaminergic effects are more subtle than those of Semax. It modulates dopamine metabolism in the striatum and cortex, contributing to its cognitive-enhancing properties. The combined modulation of GABAergic, serotonergic, and dopaminergic systems creates a unique pharmacological profile, anxiolysis with preserved or enhanced cognitive function, a combination rarely achieved with traditional anxiolytic medications.

Immunomodulatory properties represent an additional dimension of Selank's pharmacology, inherited from its parent compound tuftsin. Selank influences the expression of genes involved in immune function, including those encoding interleukins and interferons. Research has shown it can modulate the balance between pro-inflammatory and anti-inflammatory cytokines, potentially benefiting individuals with stress-related immune dysregulation.

Transcriptomic analysis has revealed that Selank modulates the expression of 84 genes in the hippocampus related to neurotransmission, signaling, metabolism, and immune function. This broad transcriptomic profile explains its multi-dimensional pharmacological effects and positions it alongside Semax as one of the most thoroughly characterized nootropic peptides in preclinical and clinical research.

Selank has been approved as a prescription medication in Russia since 2009 for treatment of generalized anxiety disorder. Clinical studies have demonstrated its efficacy in reducing anxiety symptoms comparable to benzodiazepines but without sedation, cognitive impairment, or dependence risk, significant advantages for individuals requiring anxiolytic treatment while maintaining cognitive performance.

specialist consultation is essential for Selank protocols because its modulation of multiple neurotransmitter systems may interact with psychiatric medications, and its anxiolytic mechanism should be integrated into a comprehensive treatment approach for anxiety-related conditions.

## Mechanism of Action

### Step 1: GABA-A Receptor Subunit Modulation

Selank influences expression of GABA-A receptor subunit genes (alpha-2, alpha-6), enhancing inhibitory neurotransmission through gene-level changes rather than allosteric modulation, producing anxiolysis without sedation or dependence.

### Step 2: Serotonergic Metabolism Modulation

Selank modulates serotonin and its metabolites in the hypothalamus and frontal cortex, contributing to mood stabilization and emotional regulation through pathways complementary to but distinct from SSRI mechanisms.

### Step 3: Dopaminergic Fine-Tuning

Subtle modulation of dopamine metabolism in the striatum and cortex preserves and enhances cognitive function during anxiolysis, enabling the rare combination of calm and mental clarity.

### Step 4: Immunomodulatory Signaling

As a tuftsin analogue, Selank modulates interleukin and interferon gene expression, balancing pro-inflammatory and anti-inflammatory cytokine profiles. This addresses the immune dysregulation often associated with chronic stress and anxiety.

### Step 5: Hippocampal Gene Expression

Selank modulates 84 genes in the hippocampus related to neurotransmission, signaling, and metabolism, creating a comprehensive neurochemical environment that supports both emotional stability and cognitive function.

## Researched Benefits

### Anxiolysis Without Sedation

Selank reduces anxiety through GABAergic gene expression modulation rather than receptor agonism, producing calming effects comparable to benzodiazepines without the sedation, cognitive impairment, tolerance, or dependence associated with traditional anxiolytic medications.

### Preserved Cognitive Function

Unlike most anxiolytic compounds that impair cognitive performance, Selank enhances mental clarity and focus while reducing anxiety. Its dopaminergic and serotonergic modulation supports executive function and information processing alongside its calming effects.

### Immune System Modulation

Derived from the immunomodulatory peptide tuftsin, Selank influences cytokine balance and immune gene expression. This is particularly relevant for individuals experiencing stress-related immune dysregulation, where chronic anxiety compromises immune function.

### No Dependence or Tolerance

Selank's mechanism of modulating gene expression rather than directly binding GABA receptors means it does not produce the tolerance, dependence, or withdrawal effects associated with benzodiazepines and other GABAergic drugs. This allows for sustained use under specialist supervision.

## Dosage & Administration

| Parameter | Detail |
| --- | --- |
| Protocol | 250-500mcg per day, administered intranasally in 2-3 divided doses |
| Route | Intranasal administration |
| Duration | 14-21 day cycles |
| Cycle Notes | Standard protocols run 14-21 days followed by an equal rest period. Some protocols utilize continuous lower-dose administration under specialist supervision. Effects on anxiety are typically noticed within the first week. |
| Reconstitution | Selank is typically supplied in nasal spray preparation. If supplied as lyophilized powder, reconstitute with the provided diluent. Store at 2-8°C once prepared. |

> **Specialist note:** A specialist would determine the appropriate Selank dose based on anxiety severity, existing medication regimen, and treatment goals. Individuals taking benzodiazepines, SSRIs, or other anxiolytic medications require careful protocol design to avoid neurotransmitter interactions.

## Compound Reference Data

| Property | Value |
| --- | --- |
| Format | Nasal Spray Preparation |
| Amount | 15mg total |
| Purity | >99.6% |
| Purity Method | HPLC (High-Performance Liquid Chromatography) |
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Molecular Weight | 751.90 g/mol |
| Storage | Store at 2-8°C. Protect from light. Use within 30 days of opening. |
| Appearance | Clear to slightly yellow solution |

## Medical Guidance

Selank modulates GABAergic, serotonergic, and dopaminergic neurotransmitter systems, making specialist consultation essential for anyone taking psychiatric medications including benzodiazepines, SSRIs, SNRIs, or antipsychotics. Transitioning from benzodiazepines to Selank requires careful medical supervision to avoid withdrawal complications. Individuals with psychiatric conditions should have their treatment plan holistically assessed.

## Frequently Asked Questions

### What is Selank and how does it differ from benzodiazepines?

Selank is a synthetic heptapeptide analogue of tuftsin, approved in Russia since 2009 for generalized anxiety disorder. Unlike benzodiazepines, which directly enhance GABA-A receptor function and produce sedation, tolerance, and dependence, Selank modulates GABA-A receptor subunit gene expression, a fundamentally different mechanism that produces anxiolysis without sedation, cognitive impairment, or dependence risk.

### What medical guidance applies to Selank?

Selank is a compound studied in clinical research that should only be used under qualified medical supervision. Because it modulates multiple neurotransmitter systems (GABA, serotonin, dopamine), specialist oversight ensures it is integrated safely with any existing medications and that anxiety treatment protocol is comprehensive. This is essential for both safety and optimal outcomes.

### Can Selank help with stress-related immune issues?

Selank's origin as a tuftsin analogue gives it immunomodulatory properties that traditional anxiolytics lack. Research shows it modulates interleukin and interferon gene expression, potentially rebalancing immune function disrupted by chronic stress. This dual anxiolytic-immunomodulatory profile makes it unique among anxiety-targeting compounds, though immune effects should be monitored by a specialist.

### How does Selank compare to Semax?

Selank and Semax are complementary nootropic peptides developed at the same Russian research institute. Selank primarily provides anxiolytic (calming) effects through GABAergic modulation while preserving cognition. Semax primarily provides stimulating nootropic effects through BDNF upregulation and dopaminergic enhancement. Selank suits anxiety-related cognitive impairment; Semax suits pure cognitive enhancement needs.

### What side effects have been observed with Selank?

Clinical studies and decades of use in Russia report a favorable safety profile. Unlike benzodiazepines, Selank does not cause sedation, motor impairment, tolerance, or dependence. Reported effects are generally mild and may include transient nasal irritation from intranasal delivery. A your specialist will monitor for any individual reactions and adjust the protocol accordingly.

## Related Compounds

- /compounds/semax
- /compounds/dsip
- /compounds/bpc-157

## Comparisons

- /compare/semax-vs-selank